Assignee
IMMUNEERING CORP
US·3 granted patents·5 pending applications·2 citations·filing 2010–2025
Top patents by PatentIndex Score
8 records- 0165US11043305B1Systems and methods for rapid gene set enrichment analysisIMMUNEERING CORP·Filed 2019·Granted Jun 22, 2021·2 cites·19 claims
- 0258US12351566B2MEK inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2021·Granted Jul 8, 2025·0 cites·21 claims
- 0357US2025270180A1Mek inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2025·Application pending·0 cites
- 0453US11942223B1Systems and methods for rapid gene set enrichment analysisIMMUNEERING CORP·Filed 2021·Granted Mar 26, 2024·0 cites·48 claims
- 0551US2025179057A1Mek immune oncology inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2023·Application pending·0 cites
- 0649US2026060956A1Treating pancreatic cancerIMMUNEERING CORP·Filed 2025·Application pending·0 cites
- 0740US2016154928A1Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or conditionIMMUNEERING CORP·Filed 2014·Application pending·0 cites
- 0826US2010310511A1Determining disease or immune system features based on analysis of immune system characteristicsIMMUNEERING CORP·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →